APA

Cook J. J., Glass J. D., Sitko G. R., Holahan M. A., Stupienski R. F., Wallace A. A., Stump G. L., Hand E. L., Askew B. C., Hartman G. D., Gould R. J. & Lynch J. J. (19970915). Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. : Circulation.

Chicago

Cook J J, Glass J D, Sitko G R, Holahan M A, Stupienski R F, Wallace A A, Stump G L, Hand E L, Askew B C, Hartman G D, Gould R J and Lynch J J. 19970915. Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. : Circulation.

Harvard

Cook J. J., Glass J. D., Sitko G. R., Holahan M. A., Stupienski R. F., Wallace A. A., Stump G. L., Hand E. L., Askew B. C., Hartman G. D., Gould R. J. and Lynch J. J. (19970915). Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. : Circulation.

MLA

Cook J J, Glass J D, Sitko G R, Holahan M A, Stupienski R F, Wallace A A, Stump G L, Hand E L, Askew B C, Hartman G D, Gould R J and Lynch J J. Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injury. : Circulation. 19970915.